Genomics in breast cancer-therapeutic implications (Q36303896)

13 August 2017

1 reference

title

Genomics in breast cancer-therapeutic implications (English)

1 reference

13 August 2017

0 references

Anne-Lise Børresen-Dale

series ordinal

3

object named as

Anne-Lise Børresen-Dale

1 reference

13 August 2017

1

Per Eystein Lønning

1 reference

13 August 2017

2

Therese Sørlie

1 reference

13 August 2017

1 January 2005

1 reference

Nature Clinical Practice Oncology

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

1

1 reference

13 August 2017

26-33

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

13 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Study of suboptimum treatment response: lessons from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Options available--from start to finish--for obtaining data from DNA microarrays II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Computational analysis of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Standards for microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene-expression profiles predict survival of patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Genomic profiling of gastric cancer predicts lymph node status and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Identification of high risk breast-cancer patients by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression profiling for prediction of clinical characteristics of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Outcome signature genes in breast cancer: is there a unique set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Predictive cancer genomics--what do we need?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

DNA microarrays identification of primary and secondary target genes regulated by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

The fall in breast cancer mortality in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Gene expression profiling predicts clinical outcome of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Trawling for genes that predict response to breast cancer adjuvant therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0072

7 January 2021

Identifiers

DOI

10.1038/NCPONC0072

1 reference

13 August 2017

1 reference

PubMed ID

16264853